Gene expression and association analysis of LIM (PDLIM5) in major depression

Neuroscience Letters

Volumn 400, Issue 3, 2006, Pages 203-207

  Iga, Jun ichi ^a   Ueno, Shu ichi ^a   Yamauchi, Ken ^a   Numata, Shusuke ^a   Motoki, Ikuyo ^a   Tayoshi, Sumiko ^a   Kinouchi, Sawako ^a   Ohta, Koshi ^a   Song, Hongwei ^a   Morita, Kyoko ^b   Rokutan, Kazuhito ^b   Tanabe, Hirotaka ^c   Sano, Akira ^d   Ohmori, Tetsuro ^a  

^a Medical Informatics ^*  (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c EHIME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Association analysis; Gene expression; Leukocytes; LIM (PDLIM5); Major depression; Paroxetine

Indexed keywords

MESSENGER RNA; PAROXETINE; PROTEIN; PROTEIN LIM; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION; GENOTYPE; HAMILTON SCALE; HUMAN; LEUKOCYTE; MAJOR DEPRESSION; MALE; MOOD DISORDER; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN INTERACTION; SINGLE NUCLEOTIDE POLYMORPHISM; UNINDEXED SEQUENCE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; BIOLOGICAL MARKERS; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; LEUKOCYTES; MALE; PAROXETINE; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; STATISTICS; TREATMENT OUTCOME;

EID: 33646492288     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2006.02.044     Document Type: Article

References (27)

1. American Psychiatric Association Quick reference to the diagnostic criteria from DSM-IV (1994).
2. Balkowiec A., and Katz D.M. Cellular mechanisms regulating activity-dependent release of native brain-derived neurotrophic factor from hippocampal neurons. J. Neurosci. 22 (2002) 10399-10407
3. Camp N.J., Lowry M.R., Richards R.L., Plenk A.M., Carter C., Hensel C.H., Abkevich V., Skolnick M.H., Shattuck D., Rowe K.G., Hughes D.C., and Cannon-Albright L.A. Genome-wide linkage analyses of extended Utah pedigrees identifies loci that influence recurrent, early-onset major depression and anxiety disorders. Am. J. Med. Genet. B Neuropsychiatr. Genet. 135 (2005) 85-93
4. 2+ channel complex. Cell. Signal. 18 (2006) 215-224
5. Detera-Wadleigh S.D., Badner J.A., Yoshikawa T., Sanders A.R., Goldin L.R., Turner G., Rollins D.Y., Moses T., Guroff J.J., Kazuba D., Maxwell M.E., Edenberg H.J., Foroud T., Lahiri D., Nurnberger Jr. J.I., Stine O.C., McMahon F., Meyers D.A., MacKinnon D., Simpson S., McInnis M., DePaulo J.R., Rice J., Goate A., Reich T., Blehar M.C., and Gershon E.S. Initial genome scan of the NIMH genetics initiative bipolar pedigrees: chromosomes 4, 7, 9, 18, 19, 20, and 21q. Am. J. Med. Genet. 74 (1997) 254-262
6. Henn F.A., and Vollmayr B. Stress models of depression: forming genetically vulnerable strains. Neurosci. Biobehav. Rev. 29 (2005) 799-804
7. Hill R.H., Svensson E., Dewael Y., and Grillner S. 5-HT inhibits N-type but not L-type Ca(2+) channels via 5-HT1A receptors in lamprey spinal neurons. Eur. J. Neurosci. 18 (2003) 2919-2924
8. Hodge C.W., Raber J., McMahon T., Walter H., Sanchez-Perez A.M., Olive M.F., Mehmert K., Morrow A.L., and Messing R.O. Decreased anxiety-like behavior, reduced stress hormones, and neurosteroid supersensitivity in mice lacking protein kinase Cepsilon. J. Clin. Invest. 110 (2002) 1003-1010
9. Y. Horiuchi, M. Arai, K. Niizato, S. Iritani, E. Noguchi, T. Ohtsuki, M. Koga, T. Kato, M. Itokawa, T. Arinami, A polymorphism in the PDLIM5 gene associated with gene expression and schizophrenia. Biol. Psychiatry 59 (2006) 434-439.
10. Ian A.P. Antidepressant activity and calcium signaling cascades. Hum. Psychopharmacol. Clin. Exp. 16 (2001) 71-81
11. Iga J., Ueno S., Yamauchi K., Motoki I., Tayoshi S., Ohta K., Song H., Morita K., Rokutan K., and Ohmori T. Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci. Lett. 389 (2005) 12-16
12. Irie H., Fujita M., Inokawa Y., and Narita Y. Phase I clinical study of paroxetine HCl (Study 3): pharmacokinetics after single oral administration of paroxetine HCl 10, 20 and 40 mg to healthy adult male volunteers. Jpn. Pharmacol. Ther. 28 (2000) S47-S68
13. Iwamoto K., Bundo M., Washizuka S., Kakiuchi C., and Kato T. Expression of HSPF1 and LIM in the lymphoblastoid cells derived from patients with bipolar disorder and schizophrenia. J. Hum. Genet. 49 (2004) 227-231
14. Iwamoto K., Kakiuchi C., Bundo M., Ikeda K., and Kato T. Molecular characterization of bipolar disorder by comparing gene expression profiles of postmortem brains of major mental disorders. Mol. Psychiatry 9 (2004) 406-416
15. Kato T., Iwayama Y., Kakiuchi C., Iwamoto K., Yamada K., Minabe Y., Nakamura K., Mori N., Fujii K., Nanko S., and Yoshikawa T. Gene expression and association analyses of LIM (PDLIM5) in bipolar disorder and schizophrenia. Mol. Psychiatry 10 (2005) 1045-1055
16. Lieb K., Biersack L., Waschbisch A., Orlikowski S., Akundi R.S., Candelario-Jalil E., Hull M., and Fiebich B.L. Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells. J. Neurochem. 93 (2005) 549-559
17. 2+ channels. Nat. Neurosci. 6 (2003) 468-475
18. Manji H.K., Quiroz J.A., Sporn J., Payne J.L., Denicoff K.A., Gray N., Zarate Jr. C.A., and Charney D.S. Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression. Biol. Psychiatry 53 (2003) 707-742
19. Mowry B.J., Ewen K.R., Nancarrow D.J., Lennon D.P., Nertney D.A., Jones H.L., O'Brien M.S., Thornley C.E., Walters M.K., Crowe R.R., Silverman J.M., Endicott J., Sharpe L., Hayward N.K., Gladis M.M., Foote S.J., and Levinson D.F. Second stage of a genome scan of schizophrenia: study of five positive regions in an expanded sample. Am. J. Med. Genet. 96 (2000) 864-869
20. Raison C.L., and Miller A.H. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry 160 (2003) 1554-1565
21. Rocc P., De Leo C., Eva C., Marchiaro L., Milani A.M., Musso R., Ravizza L., Zanalda E., and Bogetto F. Decrease of the D4 dopamine receptor messenger RNA expression in lymphocytes from patients with major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 26 (2002) 1155-1160
22. 2+ channel. EMBO J. 20 (2001) 2349-2356
23. Stephens M., and Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 73 (2003) 1162-1169
24. Stephens M., Smith N., and Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 68 (2001) 978-989
25. Ueki N., Seki N., Yano K., Masuho Y., Saito T., and Muramatsu M. Isolation, tissue expression, and chromosomal assignment of a human LIM protein gene, showing homology to rat enigma homologue (ENH). J. Hum. Genet. 44 (1999) 256-260
26. Urbina M., Pineda S., Pinango L., Carreira I., and Lima L. [3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int. J. Immunopharmacol. 21 (1999) 631-646
27. Williams J.B. A structured interview guide for the Hamilton Depression Rating Scale. Arch. Gen. Psychiatry 45 (1988) 742-747